Cancer in Great Danes: Bone Cancer, Early Signs, and Treatment Decisions

The cancer Great Dane owners most need to know about is osteosarcoma, an aggressive bone cancer. In a UK study of more than 900,000 dogs, Great Danes had about 34 times the odds of osteosarcoma compared with crossbred dogs, the third highest breed risk in that study (O'Neill et al., 2023). An earlier UK study of nearly 1,800 biopsy-confirmed cases also placed the Great Dane among the highest-risk breeds (Edmunds et al., 2021).

Great Danes also tend to be diagnosed with cancer young. Across all cancer types, the median age at diagnosis was 6 years for Great Danes, compared with 8.8 years for dogs overall (Rafalko et al., 2023).

The single most important thing an owner can do is refuse to assume a limp is "just a sprain." Osteosarcoma often starts as lameness that improves with rest and pain medication, which is exactly why it gets mistaken for an injury (Polton et al., 2025).

Key Points

• Great Danes had about 34 times the odds of osteosarcoma compared with crossbred dogs in UK primary care data (O'Neill et al., 2023).
• The median age at cancer diagnosis in Great Danes was 6 years in a US study of more than 3,000 dogs with cancer (Rafalko et al., 2023).
• Osteosarcoma has a small early peak between 18 and 24 months of age, so young Danes are not exempt (Polton et al., 2025).
• Early lameness often responds temporarily to rest and anti-inflammatory medication, which can lead to it being misdiagnosed as an orthopedic injury (Polton et al., 2025).
• About 90% of dogs already have microscopic spread to the lungs at diagnosis, even when chest X-rays look clear (Polton et al., 2025).
• Amputation followed by chemotherapy gives the best outcomes, and studies have shown good mobility after amputation even in giant breeds (Polton et al., 2025).

Detailed Explanation

How High Is the Great Dane Risk?

Two large UK studies have examined breed risk for osteosarcoma using different methods, and both put the Great Dane near the top.

The first compared 1,756 biopsy-confirmed osteosarcoma cases from a pathology laboratory against more than 905,000 dogs in primary veterinary care. The Rottweiler and Great Dane were at highest risk, each with more than 10 times the odds of crossbreds (Edmunds et al., 2021).

The second searched the primary care records of 905,552 dogs directly, which avoids relying on which owners could afford a biopsy. Great Danes had an odds ratio of 34.24 compared with crossbreds, behind only the Scottish Deerhound and Leonberger. About 0.87% of Great Danes under veterinary care had osteosarcoma during the one-year study period, compared with 0.037% of dogs overall (O'Neill et al., 2023).

One caution about these numbers: the second study included only 11 Great Danes with osteosarcoma, and its confidence interval for the breed ran from about 18 to 66 times the odds of crossbreds (O'Neill et al., 2023). The exact multiplier is uncertain. That the risk is very high is not.

Why Size Matters

The same research found that heavier adult bodyweight was associated with higher odds of osteosarcoma, that dogs weighing at or above the average for their breed had 1.65 times the odds of those below it, and that longer skull shape and longer legs were also associated with higher risk (O'Neill et al., 2023). Short-legged and flat-faced breeds, by contrast, were at lower risk.

The authors did not show that keeping a Dane lighter prevents cancer. The relative bodyweight finding could reflect frame size as much as body condition. It does suggest that the very features that define giant breeds are part of the risk.

Great Danes Get Cancer Young

A US study of 3,452 dogs with cancer, drawn from three cohorts, found a median age at diagnosis of 8.8 years overall. Among breeds with enough dogs to analyze, Great Danes, Saint Bernards, and Bulldogs had a median age of 6 years, and only Mastiffs were younger at 5 years (Rafalko et al., 2023). The authors suggested that annual cancer screening could reasonably begin two years before a breed's median diagnosis age, which would mean age 4 for high-risk breeds like the Great Dane.

That recommendation deserves context. All of the study's authors were employed by a company that develops blood-based cancer screening tests (Rafalko et al., 2023). The age data are useful on their own. Whether a particular screening test is worth doing is a separate question, and the 2025 osteosarcoma consensus guideline concluded there are not yet enough validated data to use liquid biopsy results for clinical decisions in dogs with osteosarcoma (Polton et al., 2025).

Osteosarcoma specifically also has an early peak. Most cases occur in middle-aged and older dogs, with reported median ages of 7 to 9 years, but there is a small first peak between 18 and 24 months (Polton et al., 2025). The UK primary care study likewise found an early peak at 2 to 3 years (O'Neill et al., 2023). A persistent limp in a young Dane is most often something else, but bone cancer belongs on the list.

The Limp That Seems to Get Better

This is the part of the article to remember.

Most dogs with osteosarcoma first show a limp that comes and goes and gradually worsens. A minor injury is sometimes reported just before it starts. The main signs are lameness, pain, and swelling near the end of a long bone, and the swelling can be hard to feel in heavily muscled areas such as the shoulder. Critically, the early signs often respond to anti-inflammatory drugs or pain medication, and the dog may be misdiagnosed with an orthopedic or soft tissue injury (Polton et al., 2025).

In other words, improvement on pain medication does not rule out bone cancer. The consensus guideline recommends early diagnostic imaging for at-risk breeds with unexplained sudden, persistent, or recurring lameness (Polton et al., 2025).

In dogs, osteosarcoma occurs about twice as often in the front legs as the back legs, most commonly near the shoulder and just above the wrist, with the knee region and ankle the common sites in the hind limb (Polton et al., 2025).

How It Is Diagnosed

X-rays of the affected bone are the starting point, and the changes of osteosarcoma are often recognizable. Other conditions, including bone infections and other tumors, can look similar, so a sample of cells from the lesion is usually recommended as the first tissue test. A fine needle aspirate is less invasive than a biopsy and is often done under sedation (Polton et al., 2025).

The consensus guideline noted that in dogs with a typical presentation, many oncologists avoid a bone biopsy before surgery because it can weaken the bone and increase fracture risk, and that confirming the diagnosis on the removed limb is acceptable when owners understand the tradeoff (Polton et al., 2025). Ask your veterinarian which approach they recommend and why.

A Clear Chest X-Ray Is Not a Clean Bill of Health

Chest imaging is part of staging, and visible lung spread is found in only a small minority of dogs at diagnosis, reported as about 5% on chest X-rays in one part of the consensus guideline and about 12% in another. However, about 90% already have microscopic spread that no X-ray can detect (Polton et al., 2025). This is why amputation alone is not a cure, and why chemotherapy is recommended even when the lungs look normal.

Treatment: What the Evidence Supports

The consensus guideline states that amputation plus chemotherapy has repeatedly produced the best outcomes, with carboplatin as the preferred single chemotherapy drug (Polton et al., 2025).

Amputation or limb-sparing surgery without chemotherapy gives median survival of only about 3 to 6 months, because of the hidden lung spread. With chemotherapy, median survival has ranged from about 8 to 14 months depending on the study and protocol, and roughly 40% of dogs are alive at one year and 20% at two years (Polton et al., 2025). Some evidence suggests starting chemotherapy within about five days of amputation offers a survival advantage (Polton et al., 2025).

There is one breed-relevant caution in the prognosis data. Dogs weighing less than 40 kg had significantly longer disease-free intervals and survival times than heavier dogs (Polton et al., 2025). Because most published survival figures come from dogs of mixed sizes, ask your oncologist whether your Dane's weight changes what you should expect.

If doxorubicin is considered as part of treatment, the guideline notes it can affect the heart, and some oncologists recommend an echocardiogram before starting it, particularly in high-risk breeds (Polton et al., 2025). Ask whether that applies to your dog.

Can a Great Dane Manage on Three Legs?

This is often the question that stops families from choosing amputation, and it is a fair one.

The consensus guideline states that studies have shown good mobility after amputation even in large and giant breed dogs, that dogs already refusing to bear weight on the leg have effectively shown they can walk on three, and that dogs are generally walking within 24 hours of surgery. The authors also offer the opinion that osteoarthritis is rarely a reason to rule out amputation, although neurological problems such as neck disc disease can rule out removing a front leg (Polton et al., 2025). A careful exam of the other three legs and the nervous system before surgery is part of good planning.

Mobility aids, such as a supportive harness, may be particularly helpful in the first days after surgery (Polton et al., 2025). Ask your team whether they can connect you with other owners of three-legged giant breeds, since hearing from them can make the decision clearer (Polton et al., 2025).

When Amputation Is Not the Right Choice

Not every dog is a good candidate, and not every family chooses surgery. Other options include:

• Limb-sparing surgery, which is appropriate only for a minority of cases and carries high complication rates, including infection and implant failure, without better survival than amputation (Polton et al., 2025).
• Stereotactic radiation therapy, which improved lameness in most dogs within about three weeks in one study of 123 dogs, but was followed by bone fractures in 41% (Polton et al., 2025).
• Palliative radiation and pain management focused on comfort (Polton et al., 2025).

The consensus guideline is clear that pain management is always the priority, whatever the treatment plan (Polton et al., 2025). Bone cancer is painful, and a dog's comfort should drive decisions at every stage. The Joys of Life Scale from the Drake Dog Cancer Foundation can help you track how good days and hard days are balancing out.

A Note on Neutering

The relationship between neutering and osteosarcoma risk is unresolved. Studies have found both increased risk and no effect, and the UK primary care study found that the apparent male predisposition in older research disappeared once body weight was accounted for (O'Neill et al., 2023; Polton et al., 2025). The consensus authors offered an opinion, labeled as such and acknowledged as controversial, that delaying neutering in at-risk breeds until skeletal maturity seems prudent (Polton et al., 2025). This is a decision to make with your veterinarian, weighing your individual dog's other health considerations.

Other Cancers

This article focuses on osteosarcoma because that is where the Great Dane-specific evidence is strongest and most consistent. Great Danes can develop any cancer that affects dogs, and the young median age at diagnosis applies to cancer overall, not only to bone tumors (Rafalko et al., 2023).

Keeping a Record

With a cancer that often starts as an on-and-off limp, a written record helps. Note which leg, when the limp started, whether it improved on medication, and whether it came back. The Dog Cancer Tracker (dogcancertracker.com) is one way to keep that history in one place so your veterinarian can see the pattern.

When to Contact a Veterinarian

Seek emergency veterinary care immediately if your Great Dane suddenly cannot bear any weight on a leg, especially after little or no trauma, or if a leg looks abnormally angled or swollen. A sudden fracture through weakened bone is an uncommon but recognized presentation of osteosarcoma (Polton et al., 2025).

Schedule a prompt appointment if your Great Dane shows:

• A limp lasting more than a few days, or one that comes back after rest or medication.
• A firm swelling near a joint, particularly near the shoulder, wrist, or knee.
• Pain when a specific area of a leg is touched.
• Reluctance to rise, climb stairs, or get into the car.
• Weight loss, reduced appetite, or lethargy, which can signal more advanced disease (Polton et al., 2025).

Questions to Ask Your Veterinarian

• My Dane is limping. Given the breed, should we take X-rays now rather than treating for a sprain first?
• If the limp improves on pain medication, does that rule out a bone tumor?
• Would a fine needle aspirate be enough to diagnose this, or do you recommend a biopsy?
• How will we stage the disease, and what does a clear chest X-ray actually tell us?
• Is my dog a good candidate for amputation, and have you checked the other legs and the neck?
• How soon after surgery should chemotherapy start?
• Does my dog's size change what outcomes we should expect?
• If doxorubicin is considered, should my dog have an echocardiogram first?
• If amputation is not right for us, what can radiation or palliative care offer?
• When should we start routine cancer screening, and which tests are actually useful?

References

Edmunds, G. L., Smalley, M. J., Beck, S., Errington, R. J., Gould, S., Winter, H., Brodbelt, D. C., & O'Neill, D. G. (2021). Dog breeds and body conformations with predisposition to osteosarcoma in the UK: A case-control study. Canine Medicine and Genetics, 8, Article 2. 

O'Neill, D. G., Edmunds, G. L., Urquhart-Gilmore, J., Church, D. B., Rutherford, L., Smalley, M. J., & Brodbelt, D. C. (2023). Dog breeds and conformations predisposed to osteosarcoma in the UK: A VetCompass study. Canine Medicine and Genetics, 10, Article 8. 

Polton, G., Borrego, J. F., Clemente-Vicario, F., Clifford, C. A., Jagielski, D., Kessler, M., Kobayashi, T., Lanore, D., Queiroga, F. L., Rodrigues, L., Tranaeus Rowe, A., Vajdovich, P., [FLAG: four additional authors], & Bergman, P. J. (2025). Osteosarcoma of the appendicular skeleton in dogs: Consensus and guidelines. Frontiers in Veterinary Science, 12, Article 1633593. 

Rafalko, J. M., Kruglyak, K. M., McCleary-Wheeler, A. L., Goyal, V., Phelps-Dunn, A., Wong, L. K., Warren, C. D., Brandstetter, G., Rosentel, M. C., DiMarzio, L., McLennan, L. M., O'Kell, A. L., Cohen, T. A., Grosu, D. S., Chibuk, J., Tsui, D. W. Y., Chorny, I., & Flory, A. (2023). Age at cancer diagnosis by breed, weight, sex, and cancer type in a cohort of more than 3,000 dogs: Determining the optimal age to initiate cancer screening in canine patients. PLOS ONE, 18(2), Article e0280795.